Microangiopathy Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Microangiopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

Arterial StiffnessAdiposityEating Behavior+3 more
University of Leipzig80 enrolled1 locationNCT04838249
Recruiting

Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center

Cardiovascular DiseasesRare DiseasesAutoimmune Diseases+5 more
Assistance Publique - Hôpitaux de Paris1,200 enrolled1 locationNCT07205861
Recruiting

Microangiopathy in Diabetes

Microvascular ComplicationsMicroangiopathy
Karolinska Institutet400 enrolled1 locationNCT07145567
Recruiting

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad)200 enrolled1 locationNCT07059026
Recruiting

Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre

Kidney TransplantMicroangiopathy
IRCCS Azienda Ospedaliero-Universitaria di Bologna250 enrolled1 locationNCT06759961
Recruiting

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy30 enrolled2 locationsNCT06715046
Recruiting
Phase 4

Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Hospices Civils de Lyon35 enrolled2 locationsNCT05743400
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852